Nang Kuang Pharmaceutical (1752.TW) Earnings Analysis
Nang Kuang Pharmaceutical (1752.TW) next reports earnings on 2026-08-12, consensus EPS 0.6 TWD. Last quarter (2025-02-20) it beat with EPS 0.85 TWD vs 0.57 TWD est (+49.1%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 15.69.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1752.TW next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | 0.6 TWD |
| Revenue estimate | 0.47B |
1752.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-02-20 | 0.85 TWD | 0.57 TWD | +49.1% | Beat |
| 2024-11-08 | 0.58 TWD | 0.87 TWD | -33.3% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
1752.TW valuation and analyst view
| Trailing P/E | 15.69 |
|---|---|
| Trailing EPS | 2.038 TWD |
| Price / book | 1.35 |
| Dividend yield | 5.05% |
| Market cap | 3.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Nang Kuang Pharmaceutical (1752.TW)'s next earnings date?
Nang Kuang Pharmaceutical is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 0.6 TWD and revenue estimate of 0.47B.
Did 1752.TW beat earnings last quarter?
In its 2025-02-20 report, 1752.TW posted EPS of 0.85 TWD versus a 0.57 TWD estimate — a beat of 49.1%.
What is 1752.TW's earnings track record?
Over the last 2 reported quarters with consensus data, 1752.TW beat estimates 1 times (50%).
What is 1752.TW's current P/E ratio and EPS?
1752.TW trades at a trailing P/E of 15.69 on trailing EPS of 2.0381959365599673 TWD.
What do analysts rate 1752.TW?
1752.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.